Lynn Megeney retweeted
Eight years of work! So proud of the whole team!
nature.com/articles/s44385-0…
Lynn Megeney retweeted
New @ScienceAdvances paper: Engineering suppressor tRNAs for effective treatment of Duchenne muscular dystrophy. #DMD tinyurl.com/36crszy6
Lynn Megeney retweeted
In his 90th yr our beloved father Elmer was called home. His was an extraordinary life, collecting legions of friends leaving a legacy of hard work & public service. He loved the forest, poetry, sport, law & good debate, the Yankees & especially his family. Deeply missed & alive in our hearts. Sleep well Pop, you earned your rest.
Lynn Megeney retweeted
Just published!! Congrat's to my post-doc Wang for getting featured on the cover of Science Signaling. So proud!! So much more to learn about phenotypic plasticity.
science.org/eprint/XZZZRR72V…
Lynn Megeney retweeted
Excited to share the news!! So proud of my postdoc Wang now promoted to Research Scientist!!
Protein coordinates responses to environmental stress: Newsroom - UT Southwestern, Dallas, Texas utsouthwestern.edu/newsroom/…
Lynn Megeney retweeted
Lung cancer patients who received an mRNA COVID-19 vaccine within a few months of immunotherapy lived nearly twice as long as unvaccinated patients. sciencenews.org/article/canc…
Lynn Megeney retweeted
Book signing with Dr Tony Sanfilippo, and his amazing wife Michelle. Tony is the author of “The doctors we need” @QueensuDOM @KingstonHSC @queensutime -a great read on how Canada can solve its doctor shortage problem-a must read!
Lynn Megeney retweeted
Interesting work from @Rudnicki_Lab in @NatureComms : Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis. tinyurl.com/4byakujj
Lynn Megeney retweeted
Excited to share our paper with Ghayda Mirzaa describing the novel SMARCA1-related NDD. Out today in Nature Communications.
rdcu.be/ePaDp
Lynn Megeney retweeted
We’re proud to celebrate @CincyKidsHeart's Jeff Molkentin, PhD, for receiving @UCincyMedicine's 2025 Daniel Drake Medal—college's highest honor! His groundbreaking work in cardiovascular biology continues to advance science & inspire next-gen researchers: scienceblog.cincinnatichildr…
Lynn Megeney retweeted
New @NatureComms paper: Alterations in peroxisome-mitochondria interplay in skeletal muscle accelerate muscle dysfunction. tinyurl.com/4knhr7mh
Lynn Megeney retweeted
Celebrating an amazing trip up Mount Kilimanjaro with daughter Elizabeth, supported by team Ultimate Kilimanjaro @UltimateKili @QueensuDOM @queensutime @KingstonHSC -19341 feet of challenging, hypoxic beauty. One of the hardest things I’ve ever done!
Lynn Megeney retweeted
New @NatureComms paper: Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy. #DMD tinyurl.com/34nufjed
Lynn Megeney retweeted
Congrats to @LorsonLab and colleagues for their new @hmg_journal paper: Novel neurofilament light (Nefl) E397K mouse models of Charcot–Marie-tooth type 2E (CMT2E) present early and chronic axonal neuropathy. tinyurl.com/y9x94c8z
Lynn Megeney retweeted
New @NatureMedicine paper: AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial. #DMD tinyurl.com/bdhwrkka
Lynn Megeney retweeted
Interesting new #JACC paper: Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation. tinyurl.com/2t5rv79t
Lynn Megeney retweeted
Happy to share that our single-cell analysis of muscle stem cells in two DMD models is now published in Cell Death & Disease. We hope this resource benefits researchers in neuromuscular disease and helps to support the development of stem cell targeted therapies for DMD.
Lynn Megeney retweeted
Huge wall cloud over East Ottawa right now! #onstorm cannot discern rotation
Lynn Megeney retweeted
Happy to share our new paper demonstrating optimization of base editing to correct the lethal ACTA2 R179H mutation in human smooth muscle cells in vitro and humanized mice, thereby rescuing multisystemic smooth muscle dysfunction syndrome. ahajournals.org/doi/abs/10.1…



















